Featured Research

from universities, journals, and other organizations

Trauma Treatment From The Sea

Date:
February 22, 2001
Source:
Office Of Naval Research
Summary:
A new trauma dressing made from marine micro-algae is designed to stop hemorrhaging by inducing blood clot formation in seconds. Called the "RDH Bandage" (Rapid Deployment Hemostat), it stops bleeding by causing red blood cells to form a plug as they come into contact with the algal compound.

Ever since Nimrod first routed his enemies on the field of battle, soldiers have dealt with bleeding and blood loss in the time-honored, traditional way - with gauze, tourniquets, pressure, even red-hot cauterizing irons - all with the hope that the body's natural clot-forming ability would take charge and stem the flow of blood. But even today, the percentage of battlefield deaths due to uncontrollable blood loss remains at 50 percent - a statistic that has not changed since the Civil War. Although there has been a reduction in mortality for those injured persons reaching full medical care, many casualties die before ever arriving at a triage unit.

This is about to change. Last December the Food and Drug Administration issued a market clearance for a new trauma dressing made from marine micro-algae designed to stop hemorrhaging by inducing blood clot formation in seconds. Called the "RDH Bandage" (Rapid Deployment Hemostat), it stops bleeding by causing red blood cells to form a plug as they come into contact with the algal compound. The formation of the red blood cell plug leads to a high local concentration of platelets and clotting factors, resulting in the formation of a normal blood clot. The RDH Bandage is the result of a three-year effort between the Office of Naval Research and Marine Polymer Technologies (MPT), a Massachusetts Company.

In 1992, MPT discovered a compound isolated from a marine micro-algae that proved to be very effective in controlling hemorrhage. The Company further developed the marine micro-algae technology into commercial products with FDA and CE Mark (European Union, U.S. and Canada) approvals for the treatment of hemorrhage in the hospital setting. The major challenge of the ONR/MPT project centered on the transition of the technology from the controlled clinical settings into uncontrolled traumatic situations encountered on the battlefield.

During the seven major military operations since the Korean War, open wounds to the extremities have been the most prevalent battlefield injury. Medical treatment of in the battlefield requires special trauma management, and peacetime surgical guidelines are sometimes impossible. The RDH Bandage is formulated to withstand desert conditions or frigid temperatures, and is lightweight and easy to carry. The RDH Bandage will become a regular part of battlefield emergency care. In addition to its major contribution in military medicine, the RDH Bandage is expected to play a critical role in the civilian trauma setting. In the U.S. each year, around 50,000 people bleed to death due to gunshot wounds, accidents, or other causes. This ONR- supported effort may contribute to the saving of a substantial number of these lives.


Story Source:

The above story is based on materials provided by Office Of Naval Research. Note: Materials may be edited for content and length.


Cite This Page:

Office Of Naval Research. "Trauma Treatment From The Sea." ScienceDaily. ScienceDaily, 22 February 2001. <www.sciencedaily.com/releases/2001/02/010220072148.htm>.
Office Of Naval Research. (2001, February 22). Trauma Treatment From The Sea. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2001/02/010220072148.htm
Office Of Naval Research. "Trauma Treatment From The Sea." ScienceDaily. www.sciencedaily.com/releases/2001/02/010220072148.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins